Home › Hemophilia › Texas › Dallas
Hemophilia clinical trials in Dallas, TX
4 studies for Hemophilia are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
RecruitingObservational study
- The University of Texas Southwestern Medical Center, Dallas
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
- North Texas Comprehensive Hemophilia Treatment Center, Dallas
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
RecruitingPhase 3
- University of Texas - Southwestern Medical Center- Site Number : 8400015, Dallas
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
RecruitingPhase 4
- UT Southwestern Medical Center, Dallas
About Hemophilia
Hemophilia is a rare disorder in which the blood does not clot normally. Usually hemophilia usually occurs in males and is inherited. Learn more.
More about Hemophilia on MedlinePlus
Hemophilia trials in other cities
- Indianapolis, IN9 studies
- Los Angeles, CA7 studies
- Seattle, WA6 studies
- Cedar Rapids, IA6 studies
- Philadelphia, PA5 studies
- Tampa, FL4 studies
- Sacramento, CA4 studies
- Atlanta, GA4 studies
- Little Rock, AR4 studies
- Greenville, NC4 studies
- Orange, CA4 studies
- San Francisco, CA3 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.